about
Circulating fibroblast growth factor 21 levels are closely associated with hepatic fat content: a cross-sectional studyEfficacy of Berberine in Patients with Non-Alcoholic Fatty Liver DiseaseThe Potential Mechanisms of Berberine in the Treatment of Nonalcoholic Fatty Liver DiseaseTetramethylpyrazine ameliorates high glucose-induced endothelial dysfunction by increasing mitochondrial biogenesis.Hypokalemia, hypomagnesemia, hypocalciuria, and recurrent tetany: Gitelman syndrome in a Chinese pedigree and literature review.A common polymorphism rs3781637 in MTNR1B is associated with type 2 diabetes and lipids levels in Han Chinese individuals.Serum-Free Thyroxine Levels Were Associated with Pulmonary Hypertension and Pulmonary Artery Systolic Pressure in Euthyroid Patients with Coronary Artery Disease.Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysisAssociation of the aldosterone synthase gene -344T>C polymorphism with essential hypertension and glucose homeostasis: a case-control study in a Han Chinese population.A rare case of watery diarrhea, hypokalemia and achlorhydria syndrome caused by pheochromocytomaBerberine reduces methylation of the MTTP promoter and alleviates fatty liver induced by a high-fat diet in rats.Berberine ameliorates nonalcoholic fatty liver disease by a global modulation of hepatic mRNA and lncRNA expression profilesLiver Fat Content Is Associated with Elevated Serum Uric Acid in the Chinese Middle-Aged and Elderly Populations: Shanghai Changfeng Study.Berberine reverses abnormal expression of L-type pyruvate kinase by DNA demethylation and histone acetylation in the livers of the non-alcoholic fatty disease rat.Effect of Berberine on promoting the excretion of cholesterol in high-fat diet-induced hyperlipidemic hamstersInfluence of Ethnicity on the Accuracy of Non-Invasive Scores Predicting Non-Alcoholic Fatty Liver Disease.Sphingosine Kinase 1 Protects Hepatocytes from Lipotoxicity via Down-regulation of IRE1α Protein ExpressionThe effects of berberine on hyperhomocysteinemia and hyperlipidemia in rats fed with a long-term high-fat diet.Thyroid Function, Prevalent Coronary Heart Disease, and Severity of Coronary Atherosclerosis in Patients Undergoing Coronary AngiographyA novel APOC2 gene mutation identified in a Chinese patient with severe hypertriglyceridemia and recurrent pancreatitisThe association of liver fat content and serum alanine aminotransferase with bone mineral density in middle-aged and elderly Chinese men and postmenopausal women.Serum retinol binding protein 4 is negatively related to estrogen in Chinese women with obesity: a cross-sectional study.The MDM2-p53-pyruvate carboxylase signalling axis couples mitochondrial metabolism to glucose-stimulated insulin secretion in pancreatic β-cellsLipid profiling of the therapeutic effects of berberine in patients with nonalcoholic fatty liver disease.Acetylation of Mitochondrial Trifunctional Protein α-Subunit Enhances Its Stability To Promote Fatty Acid Oxidation and Is Decreased in Nonalcoholic Fatty Liver Disease.Serum retinol binding protein 4 is negatively related to beta cell function in Chinese women with non-alcoholic fatty liver disease: a cross-sectional studyA indicator of visceral adipose dysfunction to evaluate metabolic health in adult Chinese.Effect of Metabolic Syndrome Score, Metabolic Syndrome, and Its Individual Components on the Prevalence and Severity of Angiographic Coronary Artery DiseaseTraditional Chinese medicine formula Qing Huo Yi Hao as superoxide anion scavenger in high glucose-treated endothelial cells.Quantification of visceral adipose tissue using lunar dual-energy X-ray absorptiometry in Asian Chinese.Antioxidative effect of the herbal remedy Qin Huo Yi Hao and its active component tetramethylpyrazine on high glucose-treated endothelial cells.Berberine ameliorates fatty acid-induced oxidative stress in human hepatoma cells.Effect of age on the diagnostic efficiency of HbA1c for diabetes in a Chinese middle-aged and elderly population: The Shanghai Changfeng Study.Assessment of liver fat content using quantitative ultrasonography to evaluate risks for metabolic diseases.Common polymorphism rs11191548 near the CYP17A1 gene is associated with hypertension and systolic blood pressure in the Han Chinese population.The comparison of coronary angiographic profiles between diabetic and nondiabetic patients with coronary artery disease in a Chinese population.Postprandial Blood Glucose Outweighs Fasting Blood Glucose and HbA1c in screening Coronary Heart Disease.Effects of tetramethylpyrazine phosphate on pancreatic islet microcirculation in SD rats.I148M variant of PNPLA3 increases the susceptibility to non-alcoholic fatty liver disease caused by obesity and metabolic disorders.Serum triglyceride, high-density lipoprotein cholesterol, apolipoprotein B, and coronary heart disease in a Chinese population undergoing coronary angiography.
P50
Q21135215-614D3070-45EF-46CF-9B68-5C150D1E3C20Q27301440-9B601A90-B3F1-4E55-A258-9A92A6E96D16Q28078754-6F17E200-5AE8-4023-A1E9-0AECBE4B99DEQ28539558-4E060BCD-6949-4944-ACDA-14EC9C243AEEQ33625736-D4099F29-7B2D-459E-AC76-DE0421A40481Q33864212-EB250F98-7C67-4319-A049-C98C98F614D8Q33876584-974CC64C-F658-463B-963D-1AF169B7AE10Q33932951-CEF73C88-4FB4-4FBB-A1A3-D72C3D92C19CQ33935313-543FA226-435C-494D-9829-725CED2F49B5Q34006784-C12893C5-2E13-4193-B75D-6C80960178A1Q34053063-6E5A95D7-6E26-42EB-AF72-2B851F10D3DDQ35047942-2CEC6016-C6FE-4D86-A533-45328F4B26E1Q35810113-7F727851-FF44-41A6-924E-0A075DCC9849Q35870837-B64F4EB0-D2BD-444A-9E45-AA05C8C8A1D6Q35996941-6D07F37C-A46F-4536-8B31-05FF9BE5465DQ36118420-617C1DFB-93BA-4626-AC57-4387B255B9E4Q36281733-55908EBF-D4D6-411A-95D3-B30827A08F3DQ36329123-43143615-1814-447E-AC9E-4C33BAE9AC5BQ36378770-DFA6097A-3F53-493D-A501-CF3DA8A0F25FQ36468985-338E1512-01DE-4F6F-995C-EB74442F8866Q36485944-01FE46F4-3D47-42F1-8FFF-594CB3FCBF8FQ36668250-135816F4-98C5-48C2-98B1-FC8A09455A0CQ36980558-104A3B68-85AE-492F-97B0-3DAAA9C1CBA9Q37258198-4D78FD70-C027-431B-B96C-7A33A8D60B42Q37287396-D92EB3CB-53E6-48E0-906B-F290DBECB092Q37418334-B430E28C-A7C1-4EF5-87E3-93593A73007BQ37459919-F0F71976-B2A0-41BC-B677-63AA82AC942EQ37711655-0D55519D-56F6-4AB6-AC06-D92CA680A084Q37729941-E39E6F77-D9F3-48BB-BC32-A4F187F27F52Q38453158-CAF6FC11-F707-446D-9729-B4977BEABE7EQ39870179-3A83FE27-A15A-4828-924B-43BED71DA678Q41200346-015FA0F1-621A-42B9-AE51-910A6A4B395DQ41488749-F07A0BF4-B15E-4D81-9223-1C867B338A93Q41517362-5F000717-E270-414A-9D18-E83A24C9F9FEQ44965401-55AD1B1E-F27E-4DD9-94C8-9F82A10C6A08Q45980099-4E5E375E-813D-419A-BBA4-89417FF4EDDAQ47145958-2DBB249D-5D51-4EED-80FA-1A83E1EB9775Q50055402-FFCBCC90-C559-4A73-98F9-7AF7D4EA6B07Q50241143-49702A44-7BDA-4B4D-9F7C-54F657BF20CCQ51000589-BF30A6DD-6E54-4296-AD14-6552A0064033
P50
description
researcher (ORCID 0000-0003-1864-7796)
@en
name
Xin Gao
@en
type
label
Xin Gao
@en
prefLabel
Xin Gao
@en
P31
P496
0000-0003-1864-7796